Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma von Chinot, Olivier L, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F, Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A, Hilton, Magalie, Abrey, Lauren, Cloughesy, Timothy

Volltext

Tomotherapy for cranio-spinal irradiation von Turcas, Andrada, Kelly, Sarah M., Clementel, Enrico, Cernea, Dana

Volltext

Deep-learning magnetic resonance imaging-based automatic segmentation for organs-at-risk in the brain: Accuracy and impact on dose distribution von Turcas, Andrada, Leucuta, Daniel, Balan, Cristina, Clementel, Enrico, Gheara, Cristina, Kacso, Alex, Kelly, Sarah M., Tanasa, Delia, Cernea, Dana, Achimas-Cadariu, Patriciu

Volltext

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma von Brandes, Alba A., Gil‐Gil, Miguel, Saran, Frank, Carpentier, Antoine F., Nowak, Anna K., Mason, Warren, Zagonel, Vittorina, Dubois, François, Finocchiaro, Gaetano, Fountzilas, George, Cernea, Dana Michaela, Chinot, Oliver, Anghel, Rodica, Ghiringhelli, Francois, Beauchesne, Patrick, Lombardi, Giuseppe, Franceschi, Enrico, Makrutzki, Martina, Mpofu, Chiedzo, Urban, Hans‐Joerg, Pichler, Josef

Volltext

Current provision and challenges for paediatric radiotherapy in Romania: A survey by the SIOP Europe QUARTET project von Turcas, Andrada, Kelly, Sarah M., Blondeel, Anne, Chirila, Monica, Cernea, Dana M., Mandeville, Henry C.

Volltext

695: Dose-Volume predictors of acute hematologic toxicity during pediatric cranio-spinal irradiation von Turcas, Andrada, Homorozeanu, Bianca, Leucuta, Daniel, Balan, Cristina, Cosnarovici, Rodica, Diaconu, Oana, Fekete, Zsolt, Gheara, Cristina, Mihut, Emilia, Olteanu, Diana, Pruteanu, Paula, Turcas, Adrian, Cernea, Dana, Achimas-Cadariu, Patriciu

Volltext

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study) von Fayette, Jérôme, Wirth, Lori, Oprean, Cristina, Udrea, Anghel, Jimeno, Antonio, Rischin, Danny, Nutting, Christopher, Harari, Paul M, Csoszi, Tibor, Cernea, Dana, O'Brien, Paul, Hanley, William D, Kapp, Amy V, Anderson, Maria, Penuel, Elicia, McCall, Bruce, Pirzkall, Andrea, Vermorken, Jan B

Volltext

Dynamics and predictors of hematologic toxicity during cranio-spinal irradiation von Turcas, Andrada, Homorozeanu, Bianca, Gheara, Cristina, Balan, Cristina, Cosnarovici, Rodica, Diaconu, Oana, Fekete, Zsolt, Mihut, Emilia, Olteanu, Diana, Pruteanu, Paula, Tipcu, Alexandru, Turcas, Adrian, Cernea, Dana, Leucuta, Daniel, Achimas-Cadariu, Patriciu

Volltext

Randomized Phase II Study of Duligotuzumab (MEHD7945A) versus Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEGHAN Study) von Jérôme FAYETTE, Lori Wirth, Cristina Oprean, Anghel Udrea, Antonio Jimeno, Danny Rischin, Christopher Nutting, Paul M. Harari, Tibor Csoszi, Dana Cernea, Paul O’Brien, William D. Hanley, Amy V. Kapp, Maria Anderson, Elicia Penuel, Bruce McCall, Andrea Pirzkall, Jan Baptist Vermorken

Volltext

ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA von Brandes, Alba, Gil, Miquel Gil, Saran, Frank, Carpentier, Antoine F, Nowak, Anna, Mason, Warren, Dubois, Francois, Finocchiaro, Gaetano, Fountzilas, George, Zagonel, Vittorina, Cernea, Dana M, Chinot, Olivier, Makrutzki, Martina, Mpofu, Chiedzo, Urban, Hans-Joerg, Pichler, Josef

Volltext

Baseline plasma matrix metalloproteinase 9 (MMP9) to predict overall survival (OS) benefit from bevacizumab (BEV) in newly diagnosed glioblastoma (GBM): Retrospective analysis of A... von Chinot, Olivier L., Garcia, Josep, Romain, Sylvie, Revil, Cedric, Cloughesy, Timothy, Mason, Warren P., Nishikawa, Ryo, Henriksson, Roger, Saran, Frank, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba Ariela, Kerloeguen, Yannick, Mancao, Christoph, Ouafik, L'Houcine, Abrey, Lauren E., Wick, Wolfgang, Tabouret, Emeline

Volltext

Sensitizer drugs for the treatment of temozolomide-resistant glioblastoma von Baritchii, Adriana, Jurj, Anca, Soritau, Olga, Tomuleasa, Ciprian, Raduly, Layos, Zanoaga, Oana, Cernea, Dana, Braicu, Cornelia, Neagoe, Ioana, Stefan Florian, Ioan

Volltext

ACTR-19. BASELINE PLASMA MATRIX METALLOPROTEINASE 9 (MMP9) PREDICTS OVERALL SURVIVAL (OS) BENEFIT FROM BEVACIZUMAB INDEPENDENTLY OF MOLECULAR SUBTYPES IN NEWLY DIAGNOSED GLIOBLASTO... von Chinot, Olivier, Garcia, Josep, Romain, Sylvie, Revil, Cedric, Cloughesy, Timothy, Mason, Warren, Nishikawa, Ryo, Henriksson, Roger, Saran, Frank, Carpentier, Antoine F., Hoang-Xuan, Khê, Kavan, Petr, Cernea, Dana M., Brandes, Alba A., Kerloeguen, Yannick, Mancao, Christoph, Ouafik, L’Houcine, Abrey, Lauren, Wick, Wolfgang, Tabouret, Emeline

Volltext

AT-18 SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NE... von Cloughesy, T., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., Brandes, A. A., Revil, C., Abrey, L., Chinot, O. L.

Volltext

BASELINE PLASMA MATRIX METALLOPROTEINASE 9 (MMP9) PREDICTS OVERALL SURVIVAL (OS) BENEFIT FROM BEVACIZUMAB INDEPENDENTLY OF MOLECULAR SUBTYPES IN NEWLY DIAGNOSED GLIOBLASTOMA: RETRO... von Chinot, Olivier, Garcia, Josep, Romain, Sylvie, Revil, Cedric, Cloughesy, Timothy, Mason, Warren, Nishikawa, Ryo, Henriksson, Roger, Saran, Frank, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana M., Brandes, Alba A., Kerloeguen, Yannick, Mancao, Christoph, Ouafik, L'Houcine, Abrey, Lauren, Wick, Wolfgang, Tabouret, Emeline

Volltext

Progression-free survival (PFS) and health-related quality of life (HRQoL) in AVAglio, a phase III study of bevacizumab (Bv), temozolomide (T), and radiotherapy (RT) in newly diagn... von Henriksson, Roger, Bottomley, Andrew, Mason, Warren, Saran, Frank, Wick, Wolfgang, Nishikawa, Ryo, Cloughesy, Timothy Francis, Carpentier, Antoine F, Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba Ariela, Hilton, Magalie, Abajo Guijarro, Ana Maria, Ravelo, Arliene, Chinot, Oliver L.

Volltext

AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEW... von Cloughesy, Tim, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A., Revil, Cedric, Abrey, Lauren, Chinot, Olivier L.

Volltext

Surgery of high grade gliomas - pros in favor of maximal cytoreductive surgery von C. Abrudan, Adriana Cocis, Dana Cernea, B. Suciu, Marilena Cheptea, I. St. Florian

Volltext

Survival analysis of patients with a PFS event who did not receive post-progression therapy in AVAglio (bevacizumab [BEV] plus radiotherapy [RT] and temozolomide [TMZ] for newly di... von Cloughesy, Tim, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A., Revil, Cedric, Abrey, Lauren, Chinot, Olivier L.

Volltext

Preparation of BaTi4O9 from Oxalates von Cernea, Marin, Chirtop, Elena, Neacsu, Dana, Pasuk, Iuliana, Iordanescu, Sergiu

Volltext